
| Patient data (#0000284) |
| Disease |
- |
| Reference |
United States:Salt Lake City |
| Template |
DNA |
| Technique |
SEQ |
| Remarks |
- |
| # Reported |
1 |
| Submitter |
Sean V. Tavtigian |
| Variant data |
| Allele |
Unknown |
| Reported pathogenicity |
Unknown |
| Concluded pathogenicity |
Unknown |
| Exon |
17 |
| DNA change |
c.7976G>C |
| BIC DNA change |
8204G>C |
| Protein change |
p.R2659T |
| Posterior P |
0.998 |
| IARC Class |
5 - Definitely pathogenic |
| Key Observational Reference |
Chenevix-Trench, G. et al., Cancer Research 66: 2019-2027, 2006. |
| Prior P reference |
Vallee MP et al., Human Mutation 37: 627-639, 2016 |
| Missense analysis Prior P |
0.81 |
| Splicing prior P |
0.34 |
| Other Prior P |
0.00 |
| Combined prior P |
0.97 |
| Segregation LR |
14.7 |
| Pathology LR |
1 |
| Sum Family LR |
1 |
| Co-occurrence LR |
1 |
| case-control LR |
- |
| Product of LRs |
14.7 |
| Comments |
- |
|